| ○種別 (必須): | □ | 学術論文 (審査論文)
| [継承] |
| ○言語 (必須): | □ | 英語
| [継承] |
| ○招待 (推奨): |
| ○審査 (推奨): |
| ○カテゴリ (推奨): | □ | 研究
| [継承] |
| ○共著種別 (推奨): |
| ○学究種別 (推奨): |
| ○組織 (推奨): |
| ○著者 (必須): | 1. | (英) Ogawa Masatoshi (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 2. | (英) Zhou Yu (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 3. | (英) Tsuji Ryosuke (日) (読)
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 4. | 笠原 二郎 ([徳島大学.大学院医歯薬学研究部.薬学域.薬科学部門.生命薬学系.神経病態解析学])
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| 5. | 後藤 惠
| ○役割 (任意): |
| ○貢献度 (任意): |
| ○学籍番号 (推奨): |
| [継承] |
| ○題名 (必須): | □ | (英) Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism (日)
| [継承] |
| ○副題 (任意): |
| ○要約 (任意): | □ | (英) Although the administration of dopamine precursor levodopa remains as the mainstay for the treatment of Parkinson's disease, long-term exposure to levodopa often causes a disabling complication, referred to as levodopa-induced dyskinesias. Therefore, the development of new therapeutic interventions to dampen levodopa-induced dyskinesias and parkinsonian motor deficits is needed in the treatment of Parkinson's disease. Intracerebral brain infusion has the merit of being able to specifically deliver any drug into any brain part. By using an intracerebral infusion system equipped with implantable, programmable, and refillable pumps, we show herein that continuous intrastriatal administration of memantine (MMT), which is a non-competitive N-methyl-D-aspartate receptor antagonist, attenuates levodopa-induced dyskinesias and parkinsonian signs in 6-hydroxydopamine-lesioned hemiparkinsonian mice that received daily levodopa treatment. Corroborating the general thought that overactivation of the striatal N-methyl-D-aspartate receptor function might generate levodopa-induced dyskinesias and parkinsonism, our results suggest that a continuous intrastriatal MMT infusion can be beneficial for the management of Parkinson's disease with levodopa-induced dyskinesias. Our study also provides indications for the prototypic use of pharmacological deep-brain modulation through intracerebral infusion systems for treating medically intractable movement disorders. (日)
| [継承] |
| ○キーワード (推奨): | 1. | (英) intracerebral brain infusion (日) (読)
| [継承] |
| 2. | (英) levodopa-induced dyskinesia (日) (読)
| [継承] |
| 3. | (英) memantine (日) (読)
| [継承] |
| 4. | (英) N-methyl-D-aspartate receptor (日) (読)
| [継承] |
| 5. | (英) Parkinson's disease (日) (読)
| [継承] |
| ○発行所 (推奨): | □ | (英) Frontiers (日) (読)
| [継承] |
| ○誌名 (必須): | □ | Frontiers in Neurology (Frontiers Media S.A.)
(eISSN: 1664-2295)
| ○ISSN (任意): | □ | 1664-2295
ISSN: 1664-2295
(eISSN: 1664-2295) Title: Frontiers in neurologyTitle(ISO): Front NeurolPublisher: Frontiers Media SA (NLM Catalog)
(Scopus)
(CrossRef)
(Scopus information is found. [need login]) | [継承] |
| [継承] |
| ○巻 (必須): |
| ○号 (必須): | □ | 10
| [継承] |
| ○頁 (必須): | □ | 1258 1258
| [継承] |
| ○都市 (任意): |
| ○年月日 (必須): | □ | 西暦 2019年 12月 5日 (令和 元年 12月 5日)
| [継承] |
| ○URL (任意): | □ | https://ci.nii.ac.jp/naid/120006778754/
| [継承] |
| ○DOI (任意): | □ | 10.3389/fneur.2019.01258 (→Scopusで検索)
| [継承] |
| ○PMID (任意): |
| ○CRID (任意): | □ | 1050583647829518720
| [継承] |
| ○NAID : | □ | 120006778754
| [継承] |
| ○WOS (任意): |
| ○Scopus (任意): | □ | 2-s2.0-85077276016
| [継承] |
| ○評価値 (任意): |
| ○被引用数 (任意): |
| ○指導教員 (推奨): |
| ○備考 (任意): |